Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Sezary Syndrome 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neuroectodermal Tumors, Primitive, Peripheral 1Myeloproliferative Disorders 1Mycosis Fungoides 1Lymphopenia 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia, Hairy Cell 1Leukemia 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1

Interventions

Fluorouracil 12Oxaliplatin 11Leucovorin 10Irinotecan 7Capecitabine 7regorafenib 4Radiotherapy 4Bevacizumab 4aflibercept 2Reverse Transcriptase Polymerase Chain Reaction 2Radiation 2Neoadjuvant Therapy 2Biopsy 2tucatinib 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1sulindac sulfone 1sargramostim 1pembrolizumab 1lonafarnib 1irofulven 1infigratinib 1dehydroftorafur 1balstilimab 1XELOX 1Trifluridine 1Trastuzumab 1Transplantation 1Sunitinib 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Rectal Neoplasms × Transplantation × Clear all
NCT00780988 2012-01-24

Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer

Stanford University

Phase 1 Withdrawn
Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡